Get the Stockscreener App
22.67
3.78%
-0.89
Castle Biosciences Inc stock is traded at $22.67, with a volume of 248.77K.
It is down -3.78% in the last 24 hours and up +8.78% over the past month.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
See More
Previous Close:
$23.56
Open:
$23.46
24h Volume:
248.77K
Relative Volume:
0.50
Market Cap:
$657.62M
Revenue:
$219.79M
Net Income/Loss:
$-57.47M
P/E Ratio:
-10.54
EPS:
-2.15
Net Cash Flow:
$-19.25M
1W Performance:
+3.90%
1M Performance:
+8.78%
6M Performance:
+8.06%
1Y Performance:
-22.50%
1-Day Range:
$22.48
$23.66
1-Week Range:
$22.00
$24.65
52-Week Range:
$14.59
$35.84
Castle Biosciences Inc Stock (CSTL) Company Profile
Name
Castle Biosciences Inc
Sector
Industry
Phone
866-788-9007
Address
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
Compare CSTL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
22.67 | 683.44M | 219.79M | -57.47M | -19.25M | -2.15 |
|
TMO
Thermo Fisher Scientific Inc
|
468.00 | 177.38B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
185.91 | 135.85B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
627.17 | 51.87B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
124.38 | 35.70B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
181.24 | 31.70B | 15.70B | 1.24B | 2.01B | 6.91 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-07-22 | Initiated | Stephens | Overweight |
| Apr-30-21 | Initiated | Lake Street | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-27-19 | Reiterated | Canaccord Genuity | Buy |
| Aug-19-19 | Initiated | BTIG Research | Buy |
| Aug-19-19 | Initiated | Canaccord Genuity | Buy |
| Aug-19-19 | Initiated | Robert W. Baird | Outperform |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
View All
Castle Biosciences Inc Stock (CSTL) Latest News
Strs Ohio Takes $366,000 Position in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award - markets.businessinsider.com
Diagnostic Testing Leader Castle Biosciences Secures 9th Workplace Award in 2025, Including Pittsburgh Honor - Stock Titan
SciBase Receives Initial Order for Clinical Study From Castle Biosciences - 富途牛牛
Castle Biosciences (NASDAQ:CSTL) Insider Sells $29,417.83 in Stock - MarketBeat
Castle Biosciences, Inc. $CSTL Shares Sold by Goldman Sachs Group Inc. - MarketBeat
Scibase receives initial order for clinical study from Castle Biosciences - MarketScreener
SciBase receives initial order for clinical study from Castle Biosciences - TradingView
Inspire Investing LLC Has $343,000 Holdings in Castle Biosciences, Inc. $CSTL - MarketBeat
Activity Recap: Does Castle Biosciences Inc have declining or rising EPSShare Buyback & Stepwise Trade Execution Plans - khodrobank.com
Risks Report: Can Castle Biosciences Inc deliver alphaJuly 2025 Chart Watch & High Conviction Buy Zone Picks - khodrobank.com
Aug Breakouts: How liquid is Castle Biosciences Inc stockJuly 2025 Spike Watch & Daily Entry Point Trade Alerts - خودرو بانک
Castle Biosciences Reports Strong Q2 2025 Financial Results - MSN
Castle Biosciences, Inc. $CSTL Shares Sold by Jacobs Levy Equity Management Inc. - MarketBeat
Shorts Report: Can Castle Biosciences Inc maintain its current growth rate2025 Breakouts & Breakdowns & AI Enhanced Trading Alerts - خودرو بانک
Castle Biosciences Named One of Newsweek’s America’s Greatest Companies 2025 - markets.businessinsider.com
Caxton Associates LLP Buys Shares of 16,440 Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences Named to Newsweek's Inaugural America's Greatest Companies List for 2025 - Quiver Quantitative
Molecular Diagnostics Leader Castle Biosciences Recognized Among America's Top 650 Companies by Newsweek - Stock Titan
Take Profit: Is Castle Biosciences Inc. in a bullish channel2025 Volatility Report & Safe Entry Trade Reports - خودرو بانک
Will Castle Biosciences Inc stock go up in YEARJuly 2025 Closing Moves & Breakout Confirmation Trade Signals - khodrobank.com
Aug Selloffs: How does Blue Ridge Bankshares Inc perform in inflationary periodsWeekly Trade Recap & Community Driven Trade Alerts - خودرو بانک
Revenue Check: Is Castle Biosciences Inc. in a consolidation phaseJuly 2025 PostEarnings & AI Enhanced Market Trend Forecasts - خودرو بانک
Stock Market Recap: Can Castle Biosciences Inc outperform in the next rallyPortfolio Gains Summary & Community Verified Swing Trade Signals - خودرو بانک
Investment Review: Whats next for Castle Biosciences Inc stockTrade Performance Summary & Stock Market Timing Techniques - خودرو بانک
Aug Big Picture: Is Castle Biosciences Inc benefiting from interest rate changesJuly 2025 PostEarnings & Accurate Intraday Trade Tips - خودرو بانک
Aug Macro: Is Castle Biosciences Inc. gaining market share2025 Biggest Moves & High Conviction Trade Alerts - خودرو بانک
Retail Surge: What is Castle Biosciences Inc. s P E ratio telling us2025 Support & Resistance & AI Enhanced Execution Alerts - خودرو بانک
Castle Biosciences (NASDAQ:CSTL Investor Five-year Losses Grow to 59% as the Stock Sheds US$77m This Past Week - 富途牛牛
Big Money Moves: Will InMed Pharmaceuticals Inc. outperform the market in YEAREarnings Summary Report & Daily Chart Pattern Signal Reports - خودرو بانک
Value Recap: Can Castle Biosciences Inc maintain its current growth rate2025 Biggest Moves & High Conviction Trade Alerts - خودرو بانک
Investment Review: Will Castle Biosciences Inc benefit from current market trends2025 Investor Takeaways & Reliable Entry Point Alerts - خودرو بانک
Is Castle Biosciences Inc. forming a bottoming baseMarket Performance Report & Fast Gain Stock Trading Tips - newser.com
Castle Biosciences (NASDAQ:CSTL) Given Buy Rating at Canaccord Genuity Group - MarketBeat
Parkman Healthcare Partners LLC Has $7.02 Million Position in Castle Biosciences, Inc. $CSTL - MarketBeat
556,485 Shares in Castle Biosciences, Inc. $CSTL Purchased by Park West Asset Management LLC - MarketBeat
Cubist Systematic Strategies LLC Grows Stock Position in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences Shows Improved Relative Price Performance; Still Shy Of Benchmark - MSN
Canaccord Genuity Keeps Their Buy Rating on Castle Biosciences (CSTL) - The Globe and Mail
New Data at American Foregut Society's 2025 Annual Meeting - GlobeNewswire
Main Owners Strengthen Their Position in SciBase - 富途牛牛
Castle Biosciences to Present New Findings on TissueCypher Barrett’s Esophagus Test at AFS 2025 Annual Meeting - Quiver Quantitative
15% of 'Low-Risk' Barrett's Patients Actually High-Risk: Castle Bio's TissueCypher Test Reveals Hidden Dangers - Stock Titan
Castle Biosciences Inc Stock (CSTL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):